Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
23.6% YoY to THB 343mn Full-quarter recognition of ‘International Advertising’ Recognised net loss from non-recurring expenses of THB 180mn from impairment of assets, loss on disposal/ write-off of
reduction in customer contact leads to a decrease in selling expenses such as expenses related to customers, etc. Furthermore, the cost of impairment loss on financial assets in 2021 decreased by 93.4 million
reduction in customer contact leads to a decrease in selling expenses such as expenses related to customers, etc. Furthermore, the cost of impairment loss on financial assets in 2021 decreased by 93.4 million
expenses was 1,719 MTHB, increased by 546 MTHB or 47% from 2016. This increment was mainly from the loss on written-off and disposal of plant and equipments and intangible assets of Solvay Biochemicals
Subsidiaries) (1) Total Assets Company’s total assets as of June 30, 2019 was 1,582.7 million baht, decreased 68.3 million baht or 4.1 percent compared to the total assets as of December 31, 2018. (1.1) Current
authorised and supervised by the home regulator that is a signatory, and established for offering for sale under the Mutual Recognition of Funds between Hong Kong Special Administrative Region of the People's
005/2017 24 November 2017 Subject: Informing on the acquisition of assets of ZIGA Innovation Public Company Limited Attention: The President The Stock Exchange of Thailand Attachment: Disclosure of
005/2017 24 November 2017 Subject: Informing on the acquisition of assets of ZIGA Innovation Public Company Limited Attention: The President The Stock Exchange of Thailand Attachment: Disclosure of
) 883 1,848 Unit : million Baht 31-Dec-18 31-Dec-17 Total Assets 30,632 32,172 Total Liabilities 20,532 19,781 Total Equity 10,101 12,391 Gr ou p HR C Gr ou p บริษัท จี สตีล จ ำกัด (มหำชน) G Steel Public